Comparative Study
doi: 10.1016/0041-3879(78)90005-3.
Activity of amikacin, erythromycin and doxycyline against Mycobacterium chelonei and Mycobacterium fortuitum
- PMID: 726085
- DOI: 10.1016/0041-3879(78)90005-3
Item in Clipboard
Comparative Study
Activity of amikacin, erythromycin and doxycyline against Mycobacterium chelonei and Mycobacterium fortuitum
Tubercle.
1978 Dec.
Abstract
The activity of amikacin, erythromycin and doxycycline was studied against 18 strains of M. fortuitum and 10 of M. chelonei. The agar dilution technique was used for the evaluation of the minimum inhibitory concentration. Between the three drugs tested, amikacin was the most active, since 66.6% of the M. fortuitum and 80% of M. chelonei strains were inhibited at 12.8 microgram/ml. It is possible that in some circumstances amikacin could be useful in the treatment of infections caused by M. fortuitum or M. chelonei.
Similar articles
-
In vitro susceptiiblity of Mycobacterium fortuitum and Mycobacterium chelonei to amikacin.J Infect Dis. 1978 Mar;137(3):318-21. doi: 10.1093/infdis/137.3.318. J Infect Dis. 1978. PMID: 632627
-
Clinical usefulness of amikacin and doxycycline in the treatment of infection due to Mycobacterium fortuitum and Mycobacterium chelonei.Rev Infect Dis. 1981 Sep-Oct;3(5):1068-74. doi: 10.1093/clinids/3.5.1068. Rev Infect Dis. 1981. PMID: 7339806
-
Disk diffusion testing with polymyxin and amikacin for differentiation of Mycobacterium fortuitum and Mycobacterium chelonei.J Clin Microbiol. 1982 Dec;16(6):1003-6. doi: 10.1128/jcm.16.6.1003-1006.1982. J Clin Microbiol. 1982. PMID: 6298271 Free PMC article.
-
A clinical case and a review of Mycobacterium fortuitum infections direct diagnosis approach and treatment in a patient with leg fractures.J Infect Dev Ctries. 2022 Oct 31;16(10):1650-1654. doi: 10.3855/jidc.16635. J Infect Dev Ctries. 2022. PMID: 36332221 Review.
-
Conservative treatment of prosthetic valve endocarditis due to Mycobacterium fortuitum.Eur J Clin Microbiol Infect Dis. 2002 Jul;21(7):539-41. doi: 10.1007/s10096-002-0763-8. Epub 2002 Jul 10. Eur J Clin Microbiol Infect Dis. 2002. PMID: 12172746 Review.
Cited by
-
Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents.Antimicrob Agents Chemother. 1979 Nov;16(5):611-4. doi: 10.1128/AAC.16.5.611. Antimicrob Agents Chemother. 1979. PMID: 526002 Free PMC article.
-
Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae.Antimicrob Agents Chemother. 1985 Dec;28(6):807-11. doi: 10.1128/AAC.28.6.807. Antimicrob Agents Chemother. 1985. PMID: 4083863 Free PMC article.
-
In vitro susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to cefmetazole.Antimicrob Agents Chemother. 1985 Feb;27(2):282-3. doi: 10.1128/AAC.27.2.282. Antimicrob Agents Chemother. 1985. PMID: 3857020 Free PMC article.